NOVARTIS UK Revenue and Competitors

Surrey Heath, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • NOVARTIS UK's estimated annual revenue is currently $54.7M per year.(i)
  • NOVARTIS UK's estimated revenue per employee is $201,000

Employee Data

  • NOVARTIS UK has 272 Employees.(i)
  • NOVARTIS UK grew their employee count by 5% last year.

NOVARTIS UK's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is NOVARTIS UK?

At Novartis we are reimagining medicine.\n\nWe reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.\n\nNovartis is a leading medicines company powered by data and digital. In the UK we are proud to be part of the country’s thriving life sciences ecosystem, bringing innovative medicines to thousands of UK patients who rely on them to treat serious diseases such as cancer, multiple sclerosis, severe asthma, eye conditions, and many more.\n\nWe have been awarded the exclusive ‘Top Employers’ certification for exceptional employee offerings for six consecutive years. About 105,000 people of 140 nationalities work at Novartis around the world, with over 1,300 based in the UK.\n\nOur people make our business. They discover, develop and facilitate access to our medicines. We have created a working environment that enables our associates to truly invest in their careers by giving them the support and flexibility they need.\n\nWe have a range of talent programmes, development schemes and wellbeing initiatives to ensure a healthy personal and work life balance.\n\nWelcome to our page. Please take a look at our Community Guidelines for details about how to use and interact with our LinkedIn page: https://tinyurl.com/yxvyuq3d

keywords:N/A

N/A

Total Funding

272

Number of Employees

$54.7M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NOVARTIS UK News

2022-04-17 - BeiGene nabs another PD-1 approval in China. Can partner ...

Can partner Novartis carry the success to US and Europe? ... is the only inactivated whole virus COVID-19 vaccine approved in the UK,...

2022-04-13 - Novartis' global revamp to cost thousands of jobs for simpler ...

Among a group of 15 large pharma companies, Novartis ranked 12th for that spend ... Hundreds of GSK employees in the U.K. have voted to strike against a...

2022-04-06 - Novartis scores accelerated FDA nod for Vijoice to treat rare ...

The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has granted conditional marketing authorization for Valneva's whole...

2019-01-25 - Novartis stockpiles drugs amid Brexit supply chain concerns

“Following Parliament’s vote, the risk of UK exiting the EU without a deal is increased and this will be hugely impactful for patients, particularly around the supply and safety of medicines,” read Novartis’s statement, referring to a Jan. 15 vote in the House of Commons rejecting a deal that Pr ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$502.8M14665%N/A